कंपनी लोड हो रही है
Just reported
Q3 2026 results
From Waters's results release of 3 नवंबर 2026; its quarterly report has since been filed.
Revenue
Actual
$1.77B
+121% y/y
+7.4% q/qGuided
$858.5M
midpoint
Above guide+106%EPS, GAAP
Actual
$0.82
-67% y/y
Guided
—
No guide given
Operating income, GAAP
Actual
$128M
-33% y/y
Guided
—
No guide given
Company outlook
Full year 2026
- Revenue$3.429B+8.3% y/y Raised +1.8%
- EPS, adjusted$14.60 – $14.70Raised +1.4%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Waters is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.$259.4BA+
IDXXIdexx Laboratories Inc.$55.5BA+
IQVIQVIA Holdings Inc.$43.7BA
ILMNIllumina, Inc.$31.3BA+
LHLabcorp Holdings Inc.$30.1BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 अक्टू॰ 2026CBGraded C, now B
MCKMckesson Corporation4 नव॰ 2026BAGraded B, now A
CVSCVS Health Corp4 नव॰ 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 नव॰ 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 अक्टू॰ 2026CAGraded C, now A
Waters Corporation की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।